Have a personal or library account? Click to login
Octenidine Dihydrochloride – Antimicrobial Activity, Adaptation and Clinical Application Cover

Octenidine Dihydrochloride – Antimicrobial Activity, Adaptation and Clinical Application

Open Access
|Sep 2025

References

  1. Alvarez-Marin R, Aires-de-Sousa M, Nordmann P, Kieffer N, Poirel L. Antimicrobial activity of octenidine against multidrug-resistant Gram-negative pathogens. Eur J Clin Microbiol Infect Dis. 2017 Dec; 36(12), 2379–2383 https://doi.org/10.1007/s10096-017-3070-0
  2. Amaral GCLS, Hassan MA, Sloniak MC, Pannuti CM, Romito GA, Villar CC. Effects of antimicrobial mouthwashes on the human oral microbiome: Systematic review of controlled clinical trials. Int J Dent Hyg. 2023 Feb 21(1):128–140. https://doi.org/10.1111/idh.12617
  3. Barreto R, Barrois B, Lambert J, Malhotra-Kumar S, Santos-Fernandes V, Monstrey S. Addressing the challenges in antisepsis: focus on povidone iodine. Int J Antimicrob Agents. 2020 Sep; 56(3):106064. https://doi.org/10.1016/j.ijantimicag.2020.106064
  4. Bharadwaj A, Rastogi A, Pandey S, Gupta S, Sohal JS. Multidrug-Resistant Bacteria: Their Mechanism of Action and Prophylaxis. Biomed Res Int. 2022 Sep; 5419874. https://doi.org/10.1155/2022/5419874
  5. Biermann CD, Kribs A, Roth B, Tantcheva-Poor I. Use and Cutaneous Side Effects of Skin Antiseptics in Extremely Low Birth Weight Infants - A Retrospective Survey of the German NICUs. Klin Padiatr. 2016 Jul; 228(4):208–212. https://doi.org/10.1055/s-0042-104122
  6. Bigliardi PL, Alsagoff SAL, El-Kafrawi HY, Pyon J-K, Wa CTC, Villa MA. Povidone iodine in wound healing: A review of current concepts and practices. International Journal of Surgery. 2017 Aug; 44:260–268. https://doi.org/10.1016/j.ijsu.2017.06.073
  7. Bock LJ, Ferguson PM, Clarke M, Pumpitakkul V, Wand ME, Fady P-E, Allison L, Fleck RA, Shepherd MJ, Mason AJ, et al. Pseudomonas aeruginosa adapts to octenidine via a combination of efflux and membrane remodelling. Commun Biol. 2021 Sep; 4(1):1058. https://doi.org/10.1038/s42003-021-02566-4
  8. Bonomo RA, Perez F, Hujer AM, Hujer KM, Vila AJ. The Real Crisis in Antimicrobial Resistance: Failure to Anticipate and Respond. Clinical Infectious Diseases. 2024 Jun; 78(6):1429–1433. https://doi.org/10.1093/cid/ciad758
  9. Brookes ZLS, McCullough M, Kumar P, McGrath C. Mouthwashes: Implications for Practice. Int Dent J. 2023 Nov; 73 Suppl 2(Suppl 2):S98–S101. https://doi.org/10.1016/j.identj.2023.08.013
  10. Calow T, Oberle K, Bruckner-Tuderman L, Jakob T, Schumann H. Contact dermatitis due to use of Octenisept in wound care. J Dtsch Dermatol Ges. 2009 Sep; 7(9):759–765. https://doi.org/10.1111/j.1610-0387.2009.07035.x
  11. Conceição T, de Lencastre H, Aires-de-Sousa M. Bactericidal activity of octenidine against Staphylococcus aureus harbouring genes encoding multidrug resistance efflux pumps. J Glob Antimicrob Resist. 2019 Mar; 16:239–241. https://doi.org/10.1016/j. jgar.2019.01.033
  12. Contaldo M, D’Ambrosio F, Ferraro GA, Di Stasio D, Di Palo MP, Serpico R, Simeone M. Antibiotics in Dentistry: A Narrative Review of the Evidence beyond the Myth. Int J Environ Res Public Health. 2023 Jun; 20(11):6025. https://doi.org/10.3390/ijerph20116025
  13. Davis SC, Harding A, Gil J, Parajon F, Valdes J, Solis M, Higa A. Effectiveness of a polyhexanide irrigation solution on methicillin-resistant Staphylococcus aureus biofilms in a porcine wound model. Int Wound J. 2017 Dec; 14(6):937–944. https://doi. org/10.1111/iwj.12734
  14. Denkel LA, Kramer TS, Schwab F, Golembus J, Wolke S, Gastmeier P, Geffers C. Chlorhexidine and octenidine susceptibility of bacterial isolates from clinical samples in a three-armed cluster randomised decolonisation trial. PLoS One. 2022 Dec; 17(12):e0278569. https://doi.org/10.1371/journal.pone.0278569
  15. Dittmann K, Schmidt T, Müller G, Cuny C, Holtfreter S, Troitzsch D, Pfaff P, Hübner N-O. Susceptibility of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) to chlorhexidine digluconate, octenidine dihydrochloride, polyhexanide, PVP-iodine and triclosan in comparison to hospital-acquired MRSA (HA-MRSA) and community-aquired MRSA (CA-MRSA): a standardized comparison. Antimicrob Resist Infect Control. 2019 Jul; 8:122. https://doi.org/10.1186/s13756-019-0580-9
  16. Dydak K, Junka A, Dydak A, Brożyna M, Paleczny J, Fijalkowski K, Kubielas G, Aniołek O, Bartoszewicz M. In Vitro Efficacy of Bacterial Cellulose Dressings Chemisorbed with Antiseptics against Biofilm Formed by Pathogens Isolated from Chronic Wounds. Int J Mol Sci. 2021 Apr; 22(8):3996. https://doi.org/10.3390/ijms22083996
  17. Eigner F, Keller S, Schmitt S, Corti S, Nolff MC. Efficiency of octenidine dihydrochloride alcohol combination compared to ethanol based skin antiseptics for preoperative skin preparation in dogs. PLoS One. 2023 Nov; 18(11):e0293211. https://doi.org/10.1371/journal.pone.0293211
  18. European Standard EN 1040:2005. “Chemical disinfectants and antiseptics – Quantitative suspension test for the evaluation of basic bactericidal activity of chemical disinfectants and antiseptics – Test method and requirements (phase 1).”
  19. European Standard EN 13727:2012+A2:201. “Chemical disinfectants and antiseptics – Quantitative suspension test for the evaluation of bactericidal activity in the medical area – Test method and requirements (Phase 2, Step 1)”
  20. Fang T, Xiong J, Wang L, Feng Z, Hang S, Yu J, Li W, Feng Y, Lu H, Jiang Y. Unexpected Inhibitory Effect of Octenidine Dihydrochloride on Candida albicans Filamentation by Impairing Ergosterol Biosynthesis and Disrupting Cell Membrane Integrity. Antibiotics (Basel). 2023 Nov; 12(12):1675. https://doi.org/10.3390/antibiotics12121675
  21. Garratt I, Aranega-Bou P, Sutton JM, Moore G, Wand ME. LongTerm Exposure to Octenidine in a Simulated Sink Trap Environment Results in Selection of Pseudomonas aeruginosa, Citrobacter, and Enterobacter Isolates with Mutations in Efflux Pump Regulators. Appl Environ Microbiol. 2021 Apr; 87(10):e00210-21. https://doi.org/10.1128/AEM.00210-21
  22. Grover V, Mahendra J, Gopalakrishnan D, Jain A. Effect of octenidine mouthwash on plaque, gingivitis, and oral microbial growth: A systematic review. Clin Exp Dent Res. 2021 Aug; 7(4):450–464. https://doi.org/10.1002/cre2.386
  23. Huang J, Fan Q, Guo M, Wu M, Wu S, Shen S, Wang X, Wang H. Octenidine dihydrochloride treatment of a meticillin-resistant Staphylococcus aureus biofilm-infected mouse wound. J Wound Care. 2021 Feb; 30(2):106–114. https://doi.org/10.12968/jowc.2021.30.2.106
  24. Hübner N-O, Siebert J, Kramer A. Octenidine Dihydrochloride, a Modern Antiseptic for Skin, Mucous Membranes and Wounds. Skin Pharmacology and Physiology. 2010 May; 23(5):244–258. https://doi.org/10.1159/000314699
  25. Junka A, Bartoszewicz M, Smutnicka D, Secewicz A, Szymczyk P. Efficacy of antiseptics containing povidone-iodine, octenidine dihydrochloride and ethacridine lactate against biofilm formed by Pseudomonas aeruginosa and Staphylococcus aureus measured with the novel biofilm-oriented antiseptics test. Int Wound J. 2014 Dec; 11(6):730–734. https://doi.org/10.1111/iwj.12057
  26. Karpiński TM. Adaptation Index (KAI) – a new indicator of adaptation and potential antimicrobial resistance. Herba Polonica. 2024 Sep; 70(3):39–46. https://doi.org/10.5604/01.3001.0054.8029
  27. Karpiński TM, Korbecka-Paczkowska M, Ożarowski M, Włodkowic D, Wyganowska ML, Seremak-Mrozikiewicz A, Cielecka-Piontek J. Adaptation to Sodium Hypochlorite and Potassium Permanganate May Lead to Their Ineffectiveness Against Candida albicans. Pharmaceuticals (Basel). 2024 Nov; 17(11):1544. https://doi.org/10.3390/ph17111544
  28. Karpiński TM, Korbecka-Paczkowska M, Stasiewicz M, Mrozikiewicz AE, Włodkowic D, Cielecka-Piontek J. Activity of Antiseptics Against Pseudomonas aeruginosa and Its Adaptation Potential. Antibiotics. 2025b Jan; 14(1):30. https://doi.org/10.3390/antibiotics14010030
  29. Karpiński TM, Ożarowski M, Paczkowska-Walendowska M, Cielecka-Piontek J. Astaxanthin demonstrates moderate or weak activity against bacterial and fungal pathogens. Food Bioscience. 2025a Mar; 65:106026. https://doi.org/10.1016/j.fbio.2025.106026
  30. Koburger T, Hübner N-O, Braun M, Siebert J, Kramer A. Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. J Antimicrob Chemother. 2010 Aug; 65(8):1712–1719. https://doi.org/10.1093/jac/dkq212
  31. Korbecka-Paczkowska M, Karpiński TM. In Vitro Assessment of Antifungal and Antibiofilm Efficacy of Commercial Mouthwashes against Candida albicans. Antibiotics (Basel). 2024 Jan; 13(2):117. https://doi.org/10.3390/antibiotics13020117
  32. Kramer A, Dissemond J, Kim S, Willy C, Mayer D, Papke R, Tuchmann F, Assadian O. Consensus on Wound Antisepsis: Update 2018. Skin Pharmacol Physiol. 2018 Dec; 31(1):28–58. https://doi.org/10.1159/000481545
  33. Krasowski G, Junka A, Paleczny J, Czajkowska J, Makomaska-Szaroszyk E, Chodaczek G, Majkowski M, Migdał P, Fijałkowski K, Kowalska-Krochmal B, et al. In Vitro Evaluation of Polihexanide, Octenidine and NaClO/HClO-Based Antiseptics against Biofilm Formed by Wound Pathogens. Membranes (Basel). 2021 Jan; 11(1):62. https://doi.org/10.3390/membranes11010062
  34. Küng E, Pietrzak J, Klaus C, Walochnik J. In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis. Int J Antimicrob Agents. 2016 Mar; 47(3):232–234. https://doi.org/10.1016/j. ijantimicag.2015.12.010
  35. Loose M, Naber KG, Purcell L, Wirth MP, Wagenlehner FME. Anti-Biofilm Effect of Octenidine and Polyhexanide on Uropathogenic Biofilm-Producing Bacteria. Urol Int. 2021 Jan; 105(3–4):278–284. https://doi.org/10.1159/000512370
  36. Malanovic N, Buttress JA, Vejzovic D, Ön A, Piller P, Kolb D, Lohner K, Strahl H. Disruption of the Cytoplasmic Membrane Structure and Barrier Function Underlies the Potent Antiseptic Activity of Octenidine in Gram-Positive Bacteria. Appl Environ Microbiol. 2022 May; 88(10):e0018022. https://doi.org/10.1128/aem.00180-22
  37. Malanovic N, Ön A, Pabst G, Zellner A, Lohner K. Octenidine: Novel insights into the detailed killing mechanism of Gram-negative bacteria at a cellular and molecular level. Int J Antimicrob Agents. 2020 Nov; 56(5):106146. https://doi.org/10.1016/j.ijantimicag.2020.106146
  38. Meister TL, Brüggemann Y, Todt D, Conzelmann C, Müller JA, Groß R, Münch J, Krawczyk A, Steinmann Jörg, Steinmann Jochen, et al. Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2. The Journal of Infectious Diseases. 2020 Oct; 222(8):1289–1292. https://doi.org/10.1093/infdis/jiaa471
  39. Mivšek AP, Petročnik P, Skubic M, Škodič Zakšek T, Jug Došler A. Umbilical Cord Management and Stump Care in Normal Childbirth in Slovenian and Croatian Maternity Hospitals. Acta Clin Croat. 2017 Dec; 56(4):773–780. https://doi.org/10.20471/acc.2017.56.04.27
  40. Nair HKR, Mrozikiewicz-Rakowska B, Pinto DS, Stuermer EK, Matiasek J, Sander J, Lázaro-Martínez JL, Ousey K, Assadian O, Kim PJ, et al. Use of wound antiseptics in practice. International Consensus Document. Wounds International.: 2023. 1–27.
  41. Nicolae Dopcea G, Dopcea I, Nanu AE, Diguţă CF, Matei F. Resistance and cross-resistance in Staphylococcus spp. strains following prolonged exposure to different antiseptics. J Glob Antimicrob Resist. 2020 Jun; 21:399–404. https://doi.org/10.1016/j.jgar.2019.10.021
  42. Novakov Mikić A, Stojic S. Study results on the use of different therapies for the treatment of vaginitis in hospitalised pregnant women. Arch Gynecol Obstet. 2015 Aug; 292(2):371–376. https://doi.org/10.1007/s00404-015-3638-9
  43. Pelling H, Bennett V, Bock LJ, Wand ME, Denham EL, MacFarlane WM, Sutton JM, Jones BV. Identification of mechanisms modulating chlorhexidine and octenidine susceptibility in Proteus mirabilis. J Appl Microbiol. 2024 Jul; 135(7):lxae173. https://doi.org/10.1093/jambio/lxae173
  44. PubChem. Octenidine Hydrochloride. [accessed 2025 Mar 4]. https://pubchem.ncbi.nlm.nih.gov/compound/51166.
  45. Rath A, Wong M, Li K, Wong A, Tan L, Tan K, Pannuti CM. Efficacy of adjunctive octenidine hydrochloride as compared to chlorhexidine and placebo as adjuncts to instrumentation in stage I-II periodontitis: A double-blinded randomized controlled trial. Int J Dent Hyg. 2024 Nov; https://doi.org/10.1111/idh.12795
  46. Rembe J-D, Huelsboemer L, Plattfaut I, Besser M, Stuermer EK. Antimicrobial Hypochlorous Wound Irrigation Solutions Demonstrate Lower Anti-biofilm Efficacy Against Bacterial Biofilm in a Complex in-vitro Human Plasma Biofilm Model (hpBIOM) Than Common Wound Antimicrobials. Front Microbiol. 2020 Oct; 11:564513. https://doi.org/10.3389/fmicb.2020.564513
  47. Schedler K, Assadian O, Brautferger U, Müller G, Koburger T, Classen S, Kramer A. Proposed phase 2/step 2 in-vitro test on basis of EN 14561 for standardised testing of the wound antiseptics PVP-iodine, chlorhexidine digluconate, polihexanide and octenidine dihydrochloride. BMC Infectious Diseases. 2017 Feb; 17(1):143. https://doi.org/10.1186/s12879-017-2220-4
  48. Schug AR, Scholtzek AD, Turnidge J, Meurer M, Schwarz S, Feßler AT. The Biocide Susceptibility Study Group null. Development of Quality Control Ranges for Biocide Susceptibility Testing. Pathogens. 2022 Feb; 11(2):223. https://doi.org/10.3390/pathogens11020223
  49. Severing A-L, Borkovic M, Stuermer EK, Rembe J-D. Composition of Challenge Substance in Standardized Antimicrobial Efficacy Testing of Wound Antimicrobials Is Essential to Correctly Simulate Efficacy in the Human Wound Micro-Environment. Biomedicines. 2022 Oct; 10(11):2751. https://doi.org/10.3390/biomedicines10112751
  50. Sharma A, Shankar R, Yadav AK, Pratap A, Ansari MA, Srivastava V. Burden of Chronic Nonhealing Wounds: An Overview of the Worldwide Humanistic and Economic Burden to the Healthcare System. Int J Low Extrem Wounds. 2024 Apr; 15347346241246339. https://doi.org/10.1177/15347346241246339
  51. Shepherd MJ, Moore G, Wand ME, Sutton JM, Bock LJ. Pseudomonas aeruginosa adapts to octenidine in the laboratory and a simulated clinical setting, leading to increased tolerance to chlorhexidine and other biocides. J Hosp Infect. 2018 Nov; 100(3):e23–e29. https://doi.org/10.1016/j.jhin.2018.03.037
  52. da Silva DAV, Dieckmann R, Makarewicz O, Hartung A, Bethe A, Grobbel M, Belik V, Pletz MW, Al Dahouk S, Neuhaus S. Biocide Susceptibility and Antimicrobial Resistance of Escherichia coli Isolated from Swine Feces, Pork Meat and Humans in Germany. Antibiotics (Basel). 2023 Apr; 12(5):823. https://doi.org/10.3390/antibiotics12050823
  53. Smeets R, Pfefferle S, Büttner H, Knobloch JK, Lütgehetmann M. Impact of Oral Rinsing with Octenidine Based Solution on SARS-CoV-2 Loads in Saliva of Infected Patients an Exploratory Study. Int J Environ Res Public Health. 2022 May; 19(9):5582. https://doi.org/10.3390/ijerph19095582
  54. Sopata M, Mrozikiewicz-Rakowska B, Jawień A, Woroń J, Malka M, Karpiński TM, Sobieszek-Kundro A, Gabriel M, Mańkowski P, Szewczyk M, et al. Statement of the Polish Wound Management Association – antimicrobial management in colonized wounds, with signs of infection and at risk of infection in the era of antibiotic resistance [in Polish]. Leczenie Ran. 2023 Dec; 20(4):124–141. doi:10.60075/lr.v20i4.59
  55. Steinhauer K, Meister TL, Todt D, Krawczyk A, Paßvogel L, Becker B, Paulmann D, Bischoff B, Pfaender S, Brill FHH, et al. Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476. J Hosp Infect. 2021 May; 111:180–183. https://doi.org/10.1016/j. jhin.2021.01.031
  56. Swidsinski A, Loening-Baucke V, Swidsinski S, Verstraelen H. Polymicrobial Gardnerella biofilm resists repeated intravaginal antiseptic treatment in a subset of women with bacterial vaginosis: a preliminary report. Arch Gynecol Obstet. 2015 Mar; 291(3):605–609. https://doi.org/10.1007/s00404-014-3484-1
  57. Tagliaferri TL, Rhode S, Muñoz P, Simon K, Krüttgen A, Stoppe C, Ruhl T, Beier JP, Horz H-P, Kim B-S. Antiseptic management of critical wounds: differential bacterial response upon exposure to antiseptics and first insights into antiseptic/phage interactions. Int J Surg. 2024 Sep; 110(9):5374–5384. https://doi.org/10.1097/JS9.0000000000001605
  58. Tirali RE, Turan Y, Akal N, Karahan ZC. In vitro antimicrobial activity of several concentrations of NaOCl and Octenisept in elimination of endodontic pathogens. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Nov; 108(5):e117-120. https://doi.org/10.1016/j.tripleo.2009.07.012
  59. Vejzovic D, Iftic A, Ön A, Semeraro EF, Malanovic N. Octenidine’s Efficacy: A Matter of Interpretation or the Influence of Experimental Setups? Antibiotics (Basel). 2022 Nov; 11(11):1665. https://doi.org/10.3390/antibiotics11111665
  60. Verspecht T, Rodriguez Herrero E, Khodaparast Ladan, Khodaparast Laleh, Boon N, Bernaerts K, Quirynen M, Teughels W. Development of antiseptic adaptation and cross-adapatation in selected oral pathogens in vitro. Sci Rep. 2019 Jun; 9(1):8326. https://doi.org/10.1038/s41598-019-44822-y
  61. Wand ME, Jamshidi S, Bock LJ, Rahman KM, Sutton JM. SmvA is an important efflux pump for cationic biocides in Klebsiella pneumoniae and other Enterobacteriaceae. Sci Rep. 2019 Feb; 9(1):1344. https://doi.org/10.1038/s41598-018-37730-0
DOI: https://doi.org/10.2478/am-2025-0014 | Journal eISSN: 2545-3149 | Journal ISSN: 0079-4252
Language: English, Polish
Page range: 182 - 191
Submitted on: Mar 7, 2025
Accepted on: Jul 23, 2025
Published on: Sep 30, 2025
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Tomasz M. Karpiński, Marzena Korbecka-Paczkowska, Agnieszka Zeidler, Wojciech Grzywna, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.